3D Bioprinting is an innovative technology that combines 3D printing techniques with biological materials to create complex living structures. It involves the layer-by-layer deposition of living cells, biomaterials, and support structures to construct functional tissues and organs. This revolutionary approach holds immense potential for applications in regenerative medicine, tissue engineering, and drug discovery. The process of 3D bioprinting begins with the creation of a digital model or blueprint of the desired tissue or organ. Bioinks, composed of living cells and supportive biomaterials, are then precisely deposited layer by layer to recreate the intricate architecture of natural tissues. Various printing technologies, including inkjet, extrusion, and laser-assisted methods, are employed to achieve accurate and reproducible results. Researchers are exploring 3D bioprinting to address the shortage of donor organs for transplantation. This technology allows for the fabrication of personalized tissues, reducing the risk of rejection and increasing the likelihood of successful transplantation. Additionally, 3D bioprinting serves as a powerful tool for studying diseases, drug testing, and creating in vitro models that closely mimic human physiology. Challenges in 3D bioprinting include optimizing printing parameters, ensuring cell viability, and replicating the complex vascularization necessary for larger tissue structures. Ongoing advancements in materials science, bioengineering, and computer-aided design contribute to the continuous evolution of 3D bioprinting, offering promising solutions for the future of healthcare.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States